| pubmed-article:6498736 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6498736 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:6498736 | lifeskim:mentions | umls-concept:C0034786 | lld:lifeskim |
| pubmed-article:6498736 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:6498736 | pubmed:dateCreated | 1984-12-27 | lld:pubmed |
| pubmed-article:6498736 | pubmed:abstractText | Androgen receptor assays have been performed on 1371 specimens of histologically confirmed primary and recurrent breast cancer. Forty-two patients who had received tamoxifen as treatment for advanced disease were assessed for objective response. Another 42 patients who had received chemotherapy were similarly studied. Patients with androgen receptor-negative tumors had a significantly poorer response rate to hormone therapy than those with receptor-positive tumors (P less than 0.05). This clinical correlation is supported by survival data of 1181 patients with primary breast cancer which showed that patients with androgen receptor-negative tumors had a highly significant trend toward shorter overall survival than those with receptor-positive tumors (P less than 0.001). Androgen receptor data added significantly to the information provided by estrogen receptor data both in terms of response to hormone treatment and survival. | lld:pubmed |
| pubmed-article:6498736 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6498736 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6498736 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:6498736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6498736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6498736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6498736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6498736 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6498736 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:6498736 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:6498736 | pubmed:author | pubmed-author:MorganF JFJ | lld:pubmed |
| pubmed-article:6498736 | pubmed:author | pubmed-author:RennieG CGC | lld:pubmed |
| pubmed-article:6498736 | pubmed:author | pubmed-author:BennettR CRC | lld:pubmed |
| pubmed-article:6498736 | pubmed:author | pubmed-author:BryanR MRM | lld:pubmed |
| pubmed-article:6498736 | pubmed:author | pubmed-author:LieT HTH | lld:pubmed |
| pubmed-article:6498736 | pubmed:author | pubmed-author:MercerR JRJ | lld:pubmed |
| pubmed-article:6498736 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6498736 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:6498736 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:6498736 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6498736 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6498736 | pubmed:pagination | 2436-40 | lld:pubmed |
| pubmed-article:6498736 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:meshHeading | pubmed-meshheading:6498736-... | lld:pubmed |
| pubmed-article:6498736 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6498736 | pubmed:articleTitle | Androgen receptors in breast cancer. | lld:pubmed |
| pubmed-article:6498736 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6498736 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6498736 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6498736 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6498736 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6498736 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6498736 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6498736 | lld:pubmed |
